Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin influence on gut microbiota
NCT03450317Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in colorectal cancer (CRC) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: gut microbiota in stool at 1 year and metabolome in biological specimens at 1 year. Status: unknown.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03450317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03450317.